BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age (2022)
Attributed to:
Blood borne viruses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2205011
Publication URI: http://dx.doi.org/10.1056/nejmoa2205011
Type: Journal Article/Review
Parent Publication: New England Journal of Medicine
Issue: 3